Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus
Open Access
- 1 August 2013
- journal article
- research article
- Published by Elsevier BV in Journal of Clinical Epidemiology
- Vol. 66 (8), S130-S137
- https://doi.org/10.1016/j.jclinepi.2013.02.015
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Neurological Disorders and Stroke (NINDS) (U01NS073476)
- NETT Network Clinical Coordinating Center (U01NS056975)
- Statistical and Data Management Center (U01NS059041)
This publication has 13 references indexed in Scilit:
- The role for pragmatic randomized controlled trials (pRCTs) in comparative effectiveness researchClinical Trials, 2012
- Adaptive Clinical TrialsPublished by American Medical Association (AMA) ,2012
- The Methods of Comparative Effectiveness ResearchAnnual Review of Public Health, 2012
- An Overview of the Adaptive Designs Accelerating Promising Trials Into Treatments (ADAPT-IT) ProjectAnnals of Emergency Medicine, 2012
- Intramuscular versus Intravenous Therapy for Prehospital Status EpilepticusNew England Journal of Medicine, 2012
- Adaptive Clinical Trials: The Promise and the CautionJournal of Clinical Oncology, 2011
- Step‐forward Randomization in Multicenter Emergency Treatment Clinical TrialsAcademic Emergency Medicine, 2010
- Barriers and opportunities for implementation of adaptive designs in pharmaceutical product developmentClinical Trials, 2010
- Good Practices for Adaptive Clinical Trials in Pharmaceutical Product DevelopmentDrug Information Journal, 2009
- Rethinking Randomized Clinical Trials for Comparative Effectiveness Research: The Need for Transformational ChangeAnnals of Internal Medicine, 2009